HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gloria Cristalli Selected Research

8-bromo-9-ethyladenine

4/2005New adenosine A2A receptor antagonists: actions on Parkinson's disease models.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Gloria Cristalli Research Topics

Disease

6Parkinson Disease (Parkinson's Disease)
03/2010 - 04/2005
4Asthma (Bronchial Asthma)
11/2010 - 01/2003
3Astrocytoma (Pilocytic Astrocytoma)
07/2011 - 03/2005
3Neoplasms (Cancer)
11/2010 - 02/2007
2Ischemia
06/2011 - 09/2007
2Central Nervous System Diseases (CNS Diseases)
01/2009 - 03/2007
2Neurodegenerative Diseases (Neurodegenerative Disease)
03/2007 - 01/2007
1Infarction (Infarctions)
08/2014
1Migraine Disorders (Migraine)
07/2013
1Chronic Pain
07/2013
1Pain (Aches)
07/2013
1Neuralgia (Stump Neuralgia)
07/2013
1Bulimia (Binge Eating)
09/2012
1Substance-Related Disorders (Drug Abuse)
02/2012
1Alcoholism (Alcohol Abuse)
02/2012
1Pathologic Processes
11/2010
1Dry Eye Syndromes (Dry Eye Syndrome)
11/2010
1Rheumatoid Arthritis
11/2010
1Tremor (Tremors)
03/2010
1Hypersensitivity (Allergy)
03/2010
1Epilepsy (Aura)
09/2009
1Focal Cortical Dysplasia
09/2009
1Adenocarcinoma
02/2008
1Spinal Cord Injuries (Spinal Cord Injury)
03/2007
1Catalepsy
04/2005
1Neuroblastoma
03/2005
1Glioma (Gliomas)
03/2005
1Infections
05/2003
1Alzheimer Disease (Alzheimer's Disease)
01/2003
1Cystic Fibrosis (Mucoviscidosis)
01/2003
1Septic Shock (Toxic Shock Syndrome)
01/2003
1Myocardial Infarction
01/2003
1Heart Diseases (Heart Disease)
01/2003
1Hypertension (High Blood Pressure)
01/2003

Drug/Important Bio-Agent (IBA)

5Adenosine (Adenocard)FDA LinkGeneric
11/2010 - 04/2005
4LigandsIBA
07/2013 - 01/2007
4Purinergic P1 Receptors (Adenosine Receptor)IBA
09/2012 - 01/2007
3Adenosine A2A Receptor (Adenosine A2A Receptors)IBA
03/2010 - 04/2005
2G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
07/2011 - 03/2010
2Anti-Inflammatory Agents (Anti-Inflammatories)IBA
11/2010 - 01/2009
28-ethoxy- 9-ethyladenineIBA
03/2010 - 04/2005
2AdenineFDA LinkGeneric
10/2009 - 03/2005
2Adenosine A2 Receptor AntagonistsIBA
06/2009 - 04/2005
29-ethyladenineIBA
06/2009 - 04/2005
12- (3- hydroxy- 3- phenyl- 1- propyn- 1- yl)- 5'- N- ethylcarboxamidoadenosineIBA
08/2014
12- (4- (2- carboxyethyl)phenethylamino)- 5'- N- ethylcarboxamidoadenosineIBA
09/2012
1Ethanol (Ethyl Alcohol)IBA
02/2012
1Purinergic P2 Receptors (ADP Receptor)IBA
06/2011
1Oxygen (Dioxygen)IBA
06/2011
1Glucose (Dextrose)FDA LinkGeneric
06/2011
1Mitogen-Activated Protein KinasesIBA
06/2011
1Tacrine (Cognex)FDA Link
03/2010
1Rhodopsin (Visual Purple)IBA
03/2010
1Protein Isoforms (Isoforms)IBA
03/2010
1Adenylyl Cyclases (Adenylyl Cyclase)IBA
10/2009
1gamma-Aminobutyric Acid (GABA)IBA
09/2009
1BromineIBA
06/2009
1pixantrone (BBR 2778)IBA
02/2008
1SteroidsIBA
03/2007
1Purinergic P1 Receptor AntagonistsIBA
03/2007
1Pharmaceutical PreparationsIBA
02/2007
18-bromo-9-ethyladenineIBA
04/2005
18-furyl-9-ethyladenineIBA
04/2005
1Haloperidol (Haldol)FDA LinkGeneric
04/2005
1rat adenine receptorIBA
03/2005
1DeoxyadenosinesIBA
05/2003
1Purinergic P1 Receptor AgonistsIBA
01/2003

Therapy/Procedure

1Therapeutics
11/2010